^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Title:

Abstract 1070: AUTO7: Anti-PSMA humanized CAR T-cell with improved persistence and resistance to tumor microenvironment for metastatic castration resistant prostate cancer (mCRPC)

Published date:
06/23/2020
Excerpt:
We demonstrated AUTO7 efficacy in an in-vivo model in which human PC3-PSMA PCa cells were engrafted into NSG mice for 3 weeks, prior to i.v. infusion of CAR T-cells....AUTO7 CAR T-cells were highly potent in cytotoxicity assays against PSMA positive tumor cell lines showing no difference to a CAR alone control.
DOI:
10.1158/1538-7445.AM2020-1070